The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
April 27th 2025
Zoldonrasib, a novel oral KRAS G12D-selective inhibitor, demonstrated promising safety and early antitumor activity in patients with previously treated non–small cell lung cancer (NSCLC), offering a potential new targeted therapy for this underserved population.
Experts Discuss South African COVID-19 Variant and What It Could Mean for Vaccines, Reopening
February 12th 2021Despite concerns about increased transmissibility, experts are optimistic that the current vaccines will provide some level of protection when combined with the body's immune response.
Watch
Nutritional Counseling Should Be Included in Cancer Treatment, Preventive Efforts
February 12th 2021Investigators found that poor diets are particularly common among adult cancer survivors who have significant sociodemographic disparities, including those who have less formal education and those who are overweight.
Read More
FDA Approves Breyanzi for Adults with Relapsed, Refractory Large B-cell Lymphoma
February 8th 2021Of 192 study participants who received Breyanzi, 73% achieved a response, including 54% who had minimal or no detectable lymphoma remaining following treatment and 19% who achieved a partial response.
Read More
Study Finds Many Families Hesitant to Take Children to Emergency Department During COVID-19 Pandemic
February 3rd 2021Study shows the greatest hesitancy in seeking emergency medical services among families living in under-resourced communities, which highlight health inequities that already exist during the pandemic.
Read More
Biden Administration Launches Federal Retail Pharmacy Program for COVID-19 Vaccine Administration
February 3rd 2021The participating national pharmacy partners and independent pharmacy networks represent more than 40,000 pharmacy locations and is a key component of the administration’s national strategy to expand access to vaccines.
Read More